nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—ATM—breast cancer	0.103	0.234	CbGaD
Caffeine—PIK3CD—breast cancer	0.0945	0.214	CbGaD
Caffeine—PIK3CB—breast cancer	0.0945	0.214	CbGaD
Caffeine—PIK3CA—breast cancer	0.0731	0.165	CbGaD
Caffeine—CYP1B1—breast cancer	0.0297	0.0673	CbGaD
Caffeine—CYP1A1—Toremifene—breast cancer	0.018	0.0595	CbGbCtD
Caffeine—CYP1A1—breast cancer	0.0161	0.0363	CbGaD
Caffeine—CYP1B1—Tamoxifen—breast cancer	0.015	0.0495	CbGbCtD
Caffeine—CYP1B1—Mitoxantrone—breast cancer	0.0146	0.0483	CbGbCtD
Caffeine—CYP2D6—breast cancer	0.012	0.027	CbGaD
Caffeine—CYP1B1—Paclitaxel—breast cancer	0.0117	0.0385	CbGbCtD
Caffeine—CYP3A4—breast cancer	0.0103	0.0232	CbGaD
Caffeine—CYP1A2—Anastrozole—breast cancer	0.0088	0.029	CbGbCtD
Caffeine—ABCB1—breast cancer	0.00854	0.0193	CbGaD
Caffeine—CYP1B1—Docetaxel—breast cancer	0.00844	0.0279	CbGbCtD
Caffeine—CYP1A2—Toremifene—breast cancer	0.00805	0.0266	CbGbCtD
Caffeine—CYP2C9—Anastrozole—breast cancer	0.00793	0.0262	CbGbCtD
Caffeine—CYP3A5—Lapatinib—breast cancer	0.00789	0.026	CbGbCtD
Caffeine—CYP2C8—Lapatinib—breast cancer	0.00758	0.025	CbGbCtD
Caffeine—ABCB1—Toremifene—breast cancer	0.00704	0.0232	CbGbCtD
Caffeine—CYP1A1—Tamoxifen—breast cancer	0.00658	0.0217	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—breast cancer	0.00629	0.0208	CbGbCtD
Caffeine—CYP3A4—Exemestane—breast cancer	0.00608	0.0201	CbGbCtD
Caffeine—CYP2C9—Idarubicin—breast cancer	0.00601	0.0198	CbGbCtD
Caffeine—CYP2C8—Raloxifene—breast cancer	0.00575	0.019	CbGbCtD
Caffeine—CYP2D6—Idarubicin—breast cancer	0.00549	0.0181	CbGbCtD
Caffeine—CYP3A7—Tamoxifen—breast cancer	0.00527	0.0174	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00527	0.0174	CbGbCtD
Caffeine—CYP3A4—Letrozole—breast cancer	0.00517	0.0171	CbGbCtD
Caffeine—ABCB1—Lapatinib—breast cancer	0.00513	0.0169	CbGbCtD
Caffeine—CYP2E1—Tamoxifen—breast cancer	0.00508	0.0168	CbGbCtD
Caffeine—CYP2E1—Mitoxantrone—breast cancer	0.00496	0.0164	CbGbCtD
Caffeine—CYP3A4—Anastrozole—breast cancer	0.00461	0.0152	CbGbCtD
Caffeine—CYP3A4—Toremifene—breast cancer	0.00422	0.0139	CbGbCtD
Caffeine—CYP3A7—Paclitaxel—breast cancer	0.0041	0.0135	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0041	0.0135	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00404	0.0133	CbGbCtD
Caffeine—CYP3A7—Irinotecan—breast cancer	0.00404	0.0133	CbGbCtD
Caffeine—CYP3A5—Tamoxifen—breast cancer	0.00395	0.013	CbGbCtD
Caffeine—CYP3A4—Fulvestrant—breast cancer	0.00392	0.0129	CbGbCtD
Caffeine—CYP2C8—Tamoxifen—breast cancer	0.0038	0.0125	CbGbCtD
Caffeine—CYP3A4—Thiotepa—breast cancer	0.00349	0.0115	CbGbCtD
Caffeine—CYP2C9—Capecitabine—breast cancer	0.00329	0.0109	CbGbCtD
Caffeine—CYP3A4—Ixabepilone—breast cancer	0.0032	0.0105	CbGbCtD
Caffeine—CYP3A4—Lapatinib—breast cancer	0.00308	0.0102	CbGbCtD
Caffeine—CYP3A5—Paclitaxel—breast cancer	0.00307	0.0101	CbGbCtD
Caffeine—CYP3A5—Irinotecan—breast cancer	0.00303	0.01	CbGbCtD
Caffeine—CYP3A7—Docetaxel—breast cancer	0.00296	0.00978	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00296	0.00978	CbGbCtD
Caffeine—CYP2C8—Paclitaxel—breast cancer	0.00296	0.00976	CbGbCtD
Caffeine—CYP1A2—Tamoxifen—breast cancer	0.00294	0.0097	CbGbCtD
Caffeine—ABCB1—Vinorelbine—breast cancer	0.00285	0.0094	CbGbCtD
Caffeine—CYP2C8—Fluorouracil—breast cancer	0.0028	0.00924	CbGbCtD
Caffeine—CYP2D6—Vinorelbine—breast cancer	0.00268	0.00886	CbGbCtD
Caffeine—CYP2C9—Tamoxifen—breast cancer	0.00265	0.00874	CbGbCtD
Caffeine—ABCB1—Tamoxifen—breast cancer	0.00257	0.00848	CbGbCtD
Caffeine—ABCB1—Mitoxantrone—breast cancer	0.00251	0.00827	CbGbCtD
Caffeine—CYP2D6—Tamoxifen—breast cancer	0.00242	0.00799	CbGbCtD
Caffeine—CYP3A4—Raloxifene—breast cancer	0.00233	0.00769	CbGbCtD
Caffeine—CYP3A5—Docetaxel—breast cancer	0.00222	0.00734	CbGbCtD
Caffeine—ABCB1—Gemcitabine—breast cancer	0.00221	0.00731	CbGbCtD
Caffeine—CYP1A2—Fluorouracil—breast cancer	0.00217	0.00715	CbGbCtD
Caffeine—CYP2C9—Paclitaxel—breast cancer	0.00206	0.0068	CbGbCtD
Caffeine—ABCB1—Paclitaxel—breast cancer	0.002	0.0066	CbGbCtD
Caffeine—ABCB1—Irinotecan—breast cancer	0.00197	0.00651	CbGbCtD
Caffeine—CYP2C9—Fluorouracil—breast cancer	0.00195	0.00644	CbGbCtD
Caffeine—ABCB1—Vinblastine—breast cancer	0.00176	0.00579	CbGbCtD
Caffeine—CYP3A4—Vinorelbine—breast cancer	0.00171	0.00563	CbGbCtD
Caffeine—CYP2D6—Vinblastine—breast cancer	0.00165	0.00546	CbGbCtD
Caffeine—CYP3A4—Tamoxifen—breast cancer	0.00154	0.00508	CbGbCtD
Caffeine—CYP3A4—Mitoxantrone—breast cancer	0.0015	0.00496	CbGbCtD
Caffeine—ABCB1—Docetaxel—breast cancer	0.00145	0.00477	CbGbCtD
Caffeine—ATM—mammary gland—breast cancer	0.00138	0.0274	CbGeAlD
Caffeine—PRKDC—mammary gland—breast cancer	0.00131	0.0259	CbGeAlD
Caffeine—PIK3CD—mammary gland—breast cancer	0.00123	0.0243	CbGeAlD
Caffeine—CYP3A4—Paclitaxel—breast cancer	0.0012	0.00396	CbGbCtD
Caffeine—CYP3A4—Irinotecan—breast cancer	0.00118	0.0039	CbGbCtD
Caffeine—PIK3CA—Estradiol—Fulvestrant—breast cancer	0.00116	0.529	CbGdCrCtD
Caffeine—PRKDC—nipple—breast cancer	0.00108	0.0214	CbGeAlD
Caffeine—ABCB1—Doxorubicin—breast cancer	0.00108	0.00356	CbGbCtD
Caffeine—PIK3CA—mammary gland—breast cancer	0.00106	0.021	CbGeAlD
Caffeine—CYP3A4—Vinblastine—breast cancer	0.00105	0.00347	CbGbCtD
Caffeine—ABCB1—Methotrexate—breast cancer	0.00104	0.00345	CbGbCtD
Caffeine—CYP2D6—Doxorubicin—breast cancer	0.00102	0.00335	CbGbCtD
Caffeine—ATM—embryo—breast cancer	0.000945	0.0187	CbGeAlD
Caffeine—PIK3CB—nipple—breast cancer	0.000886	0.0175	CbGeAlD
Caffeine—RYR1—nipple—breast cancer	0.000877	0.0174	CbGeAlD
Caffeine—PIK3CA—nipple—breast cancer	0.000877	0.0174	CbGeAlD
Caffeine—CYP3A4—Docetaxel—breast cancer	0.000867	0.00286	CbGbCtD
Caffeine—PIK3CD—embryo—breast cancer	0.000838	0.0166	CbGeAlD
Caffeine—ATM—epithelium—breast cancer	0.000771	0.0153	CbGeAlD
Caffeine—ATM—skin of body—breast cancer	0.000733	0.0145	CbGeAlD
Caffeine—PIK3CB—embryo—breast cancer	0.000731	0.0145	CbGeAlD
Caffeine—PIK3CA—embryo—breast cancer	0.000723	0.0143	CbGeAlD
Caffeine—PIK3CD—epithelium—breast cancer	0.000684	0.0135	CbGeAlD
Caffeine—PRKDC—endometrium—breast cancer	0.000654	0.0129	CbGeAlD
Caffeine—PIK3CD—skin of body—breast cancer	0.00065	0.0129	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—breast cancer	0.000646	0.00213	CbGbCtD
Caffeine—ADORA2B—nipple—breast cancer	0.000645	0.0128	CbGeAlD
Caffeine—ATM—uterus—breast cancer	0.000637	0.0126	CbGeAlD
Caffeine—ATM—adipose tissue—breast cancer	0.000623	0.0123	CbGeAlD
Caffeine—PRKDC—uterus—breast cancer	0.000602	0.0119	CbGeAlD
Caffeine—PIK3CB—epithelium—breast cancer	0.000596	0.0118	CbGeAlD
Caffeine—PRKDC—pituitary gland—breast cancer	0.000592	0.0117	CbGeAlD
Caffeine—PIK3CA—epithelium—breast cancer	0.00059	0.0117	CbGeAlD
Caffeine—PRKDC—adipose tissue—breast cancer	0.000589	0.0117	CbGeAlD
Caffeine—ATM—female reproductive system—breast cancer	0.000573	0.0113	CbGeAlD
Caffeine—PIK3CB—skin of body—breast cancer	0.000567	0.0112	CbGeAlD
Caffeine—PIK3CA—skin of body—breast cancer	0.000561	0.0111	CbGeAlD
Caffeine—Oxtriphylline—PDE4D—breast cancer	0.000561	0.301	CrCbGaD
Caffeine—ATM—adrenal gland—breast cancer	0.000559	0.0111	CbGeAlD
Caffeine—PIK3CD—pituitary gland—breast cancer	0.000555	0.011	CbGeAlD
Caffeine—PIK3CD—adipose tissue—breast cancer	0.000553	0.0109	CbGeAlD
Caffeine—ATM—bone marrow—breast cancer	0.000541	0.0107	CbGeAlD
Caffeine—PIK3CB—endometrium—breast cancer	0.000535	0.0106	CbGeAlD
Caffeine—PIK3CA—endometrium—breast cancer	0.000529	0.0105	CbGeAlD
Caffeine—PRKDC—adrenal gland—breast cancer	0.000529	0.0105	CbGeAlD
Caffeine—ATM—female gonad—breast cancer	0.000521	0.0103	CbGeAlD
Caffeine—PRKDC—bone marrow—breast cancer	0.000511	0.0101	CbGeAlD
Caffeine—PIK3CD—female reproductive system—breast cancer	0.000508	0.0101	CbGeAlD
Caffeine—PIK3CD—adrenal gland—breast cancer	0.000496	0.00981	CbGeAlD
Caffeine—PIK3CB—uterus—breast cancer	0.000493	0.00976	CbGeAlD
Caffeine—PRKDC—female gonad—breast cancer	0.000493	0.00976	CbGeAlD
Caffeine—RYR1—uterus—breast cancer	0.000488	0.00966	CbGeAlD
Caffeine—PIK3CA—uterus—breast cancer	0.000488	0.00966	CbGeAlD
Caffeine—ATM—endocrine gland—breast cancer	0.000485	0.0096	CbGeAlD
Caffeine—PIK3CB—pituitary gland—breast cancer	0.000484	0.00958	CbGeAlD
Caffeine—PIK3CB—adipose tissue—breast cancer	0.000482	0.00954	CbGeAlD
Caffeine—PIK3CD—bone marrow—breast cancer	0.00048	0.00949	CbGeAlD
Caffeine—PIK3CA—pituitary gland—breast cancer	0.000479	0.00948	CbGeAlD
Caffeine—PIK3CA—adipose tissue—breast cancer	0.000477	0.00944	CbGeAlD
Caffeine—Dyphylline—PDE4D—breast cancer	0.000477	0.256	CrCbGaD
Caffeine—PIK3CD—female gonad—breast cancer	0.000462	0.00915	CbGeAlD
Caffeine—PIK3CB—female reproductive system—breast cancer	0.000443	0.00877	CbGeAlD
Caffeine—RYR1—female reproductive system—breast cancer	0.000438	0.00868	CbGeAlD
Caffeine—PIK3CA—female reproductive system—breast cancer	0.000438	0.00868	CbGeAlD
Caffeine—PIK3CB—adrenal gland—breast cancer	0.000432	0.00856	CbGeAlD
Caffeine—PIK3CD—endocrine gland—breast cancer	0.00043	0.00851	CbGeAlD
Caffeine—RYR1—adrenal gland—breast cancer	0.000428	0.00847	CbGeAlD
Caffeine—PIK3CA—adrenal gland—breast cancer	0.000428	0.00847	CbGeAlD
Caffeine—PIK3CB—bone marrow—breast cancer	0.000418	0.00828	CbGeAlD
Caffeine—PIK3CA—bone marrow—breast cancer	0.000414	0.0082	CbGeAlD
Caffeine—PIK3CB—female gonad—breast cancer	0.000403	0.00798	CbGeAlD
Caffeine—PIK3CA—female gonad—breast cancer	0.000399	0.0079	CbGeAlD
Caffeine—PIK3CB—endocrine gland—breast cancer	0.000375	0.00742	CbGeAlD
Caffeine—RYR1—endocrine gland—breast cancer	0.000371	0.00735	CbGeAlD
Caffeine—PIK3CA—endocrine gland—breast cancer	0.000371	0.00735	CbGeAlD
Caffeine—CYP1B1—mammary gland—breast cancer	0.000355	0.00703	CbGeAlD
Caffeine—ADORA2B—pituitary gland—breast cancer	0.000352	0.00698	CbGeAlD
Caffeine—ADORA2B—adipose tissue—breast cancer	0.000351	0.00695	CbGeAlD
Caffeine—PDE4B—nipple—breast cancer	0.000343	0.00679	CbGeAlD
Caffeine—Theophylline—PDE4D—breast cancer	0.00034	0.183	CrCbGaD
Caffeine—ATM—lymph node—breast cancer	0.000335	0.00663	CbGeAlD
Caffeine—PRKDC—lymph node—breast cancer	0.000317	0.00627	CbGeAlD
Caffeine—PIK3CD—lymph node—breast cancer	0.000297	0.00588	CbGeAlD
Caffeine—PRKDC—Testosterone—Exemestane—breast cancer	0.000281	0.127	CbGdCrCtD
Caffeine—CYP2C8—mammary gland—breast cancer	0.000272	0.00538	CbGeAlD
Caffeine—ADORA2A—female reproductive system—breast cancer	0.000268	0.00531	CbGeAlD
Caffeine—ADORA2A—adrenal gland—breast cancer	0.000262	0.00519	CbGeAlD
Caffeine—PRKDC—Vinblastine—Vinorelbine—breast cancer	0.000261	0.118	CbGdCrCtD
Caffeine—PIK3CB—lymph node—breast cancer	0.000259	0.00513	CbGeAlD
Caffeine—PIK3CA—lymph node—breast cancer	0.000256	0.00508	CbGeAlD
Caffeine—ADORA1—adipose tissue—breast cancer	0.000252	0.00499	CbGeAlD
Caffeine—CYP3A7—endocrine gland—breast cancer	0.000244	0.00483	CbGeAlD
Caffeine—CYP2C9—mammary gland—breast cancer	0.000242	0.00478	CbGeAlD
Caffeine—ADORA1—female reproductive system—breast cancer	0.000232	0.00459	CbGeAlD
Caffeine—ADORA2A—endocrine gland—breast cancer	0.000227	0.0045	CbGeAlD
Caffeine—Theophylline—CYP1B1—breast cancer	0.000211	0.114	CrCbGaD
Caffeine—CYP1A2—nipple—breast cancer	0.000211	0.00417	CbGeAlD
Caffeine—CYP1A1—nipple—breast cancer	0.000208	0.00411	CbGeAlD
Caffeine—PDE4B—endometrium—breast cancer	0.000207	0.0041	CbGeAlD
Caffeine—ADORA1—endocrine gland—breast cancer	0.000196	0.00388	CbGeAlD
Caffeine—PRKDC—Testosterone—Fluoxymesterone—breast cancer	0.000194	0.0884	CbGdCrCtD
Caffeine—CYP1B1—skin of body—breast cancer	0.000188	0.00372	CbGeAlD
Caffeine—PDE4B—pituitary gland—breast cancer	0.000187	0.00371	CbGeAlD
Caffeine—PDE4B—adipose tissue—breast cancer	0.000187	0.00369	CbGeAlD
Caffeine—PDE4B—female reproductive system—breast cancer	0.000171	0.00339	CbGeAlD
Caffeine—PDE4B—adrenal gland—breast cancer	0.000167	0.00331	CbGeAlD
Caffeine—CYP1B1—uterus—breast cancer	0.000163	0.00324	CbGeAlD
Caffeine—PDE4B—bone marrow—breast cancer	0.000162	0.0032	CbGeAlD
Caffeine—CYP1B1—pituitary gland—breast cancer	0.00016	0.00318	CbGeAlD
Caffeine—CYP1B1—adipose tissue—breast cancer	0.00016	0.00316	CbGeAlD
Caffeine—PRKDC—Danazol—Fluoxymesterone—breast cancer	0.000158	0.0717	CbGdCrCtD
Caffeine—PDE4B—female gonad—breast cancer	0.000156	0.00309	CbGeAlD
Caffeine—CYP1B1—female reproductive system—breast cancer	0.000147	0.00291	CbGeAlD
Caffeine—PDE4B—endocrine gland—breast cancer	0.000145	0.00287	CbGeAlD
Caffeine—CYP1B1—adrenal gland—breast cancer	0.000143	0.00284	CbGeAlD
Caffeine—PRKDC—Norethindrone—Fluoxymesterone—breast cancer	0.000142	0.0646	CbGdCrCtD
Caffeine—CYP1A1—epithelium—breast cancer	0.00014	0.00277	CbGeAlD
Caffeine—CYP2C8—endometrium—breast cancer	0.000136	0.00269	CbGeAlD
Caffeine—ADORA1—lymph node—breast cancer	0.000136	0.00268	CbGeAlD
Caffeine—CYP1B1—female gonad—breast cancer	0.000134	0.00265	CbGeAlD
Caffeine—CYP1A1—skin of body—breast cancer	0.000133	0.00263	CbGeAlD
Caffeine—CYP1B1—endocrine gland—breast cancer	0.000124	0.00246	CbGeAlD
Caffeine—CYP2C8—pituitary gland—breast cancer	0.000123	0.00243	CbGeAlD
Caffeine—CYP1A1—uterus—breast cancer	0.000116	0.00229	CbGeAlD
Caffeine—Theophylline—CYP1A1—breast cancer	0.000114	0.0614	CrCbGaD
Caffeine—CYP1A1—adipose tissue—breast cancer	0.000113	0.00224	CbGeAlD
Caffeine—CYP2C8—female reproductive system—breast cancer	0.000113	0.00223	CbGeAlD
Caffeine—CYP3A5—adipose tissue—breast cancer	0.00011	0.00219	CbGeAlD
Caffeine—CYP1A1—female reproductive system—breast cancer	0.000104	0.00206	CbGeAlD
Caffeine—PDE4B—lymph node—breast cancer	0.0001	0.00199	CbGeAlD
Caffeine—CYP2C9—female reproductive system—breast cancer	9.99e-05	0.00198	CbGeAlD
Caffeine—Haemoglobin—Mitoxantrone—breast cancer	9.74e-05	0.00127	CcSEcCtD
Caffeine—Infection—Tamoxifen—breast cancer	9.69e-05	0.00127	CcSEcCtD
Caffeine—Haemorrhage—Mitoxantrone—breast cancer	9.69e-05	0.00127	CcSEcCtD
Caffeine—Haemorrhage—Irinotecan—breast cancer	9.69e-05	0.00127	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—breast cancer	9.68e-05	0.00127	CcSEcCtD
Caffeine—Rash—Ixabepilone—breast cancer	9.55e-05	0.00125	CcSEcCtD
Caffeine—Dermatitis—Ixabepilone—breast cancer	9.54e-05	0.00125	CcSEcCtD
Caffeine—CYP2C8—endocrine gland—breast cancer	9.52e-05	0.00189	CbGeAlD
Caffeine—Infection—Melphalan—breast cancer	9.49e-05	0.00124	CcSEcCtD
Caffeine—Nervousness—Thiotepa—breast cancer	9.49e-05	0.00124	CcSEcCtD
Caffeine—Haemoglobin—Gemcitabine—breast cancer	9.49e-05	0.00124	CcSEcCtD
Caffeine—CYP2E1—female reproductive system—breast cancer	9.47e-05	0.00188	CbGeAlD
Caffeine—Gastrointestinal disorder—Chlorambucil—breast cancer	9.46e-05	0.00124	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—breast cancer	9.45e-05	0.00124	CcSEcCtD
Caffeine—CYP1A1—female gonad—breast cancer	9.45e-05	0.00187	CbGeAlD
Caffeine—Haemorrhage—Gemcitabine—breast cancer	9.44e-05	0.00123	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Capecitabine—breast cancer	9.37e-05	0.00123	CcSEcCtD
Caffeine—Haemoglobin—Fluorouracil—breast cancer	9.33e-05	0.00122	CcSEcCtD
Caffeine—Tachycardia—Melphalan—breast cancer	9.33e-05	0.00122	CcSEcCtD
Caffeine—Haemorrhage—Fluorouracil—breast cancer	9.28e-05	0.00121	CcSEcCtD
Caffeine—Skin disorder—Melphalan—breast cancer	9.28e-05	0.00121	CcSEcCtD
Caffeine—Infection—Goserelin—breast cancer	9.26e-05	0.00121	CcSEcCtD
Caffeine—CYP2E1—adrenal gland—breast cancer	9.24e-05	0.00183	CbGeAlD
Caffeine—CYP3A5—female gonad—breast cancer	9.24e-05	0.00183	CbGeAlD
Caffeine—Nervous system disorder—Goserelin—breast cancer	9.14e-05	0.0012	CcSEcCtD
Caffeine—Tachycardia—Goserelin—breast cancer	9.1e-05	0.00119	CcSEcCtD
Caffeine—Skin disorder—Goserelin—breast cancer	9.05e-05	0.00118	CcSEcCtD
Caffeine—Cardiac disorder—Irinotecan—breast cancer	8.99e-05	0.00118	CcSEcCtD
Caffeine—Rash—Anastrozole—breast cancer	8.99e-05	0.00118	CcSEcCtD
Caffeine—Rash—Letrozole—breast cancer	8.99e-05	0.00118	CcSEcCtD
Caffeine—Dermatitis—Letrozole—breast cancer	8.98e-05	0.00117	CcSEcCtD
Caffeine—Dermatitis—Anastrozole—breast cancer	8.98e-05	0.00117	CcSEcCtD
Caffeine—Agitation—Thiotepa—breast cancer	8.98e-05	0.00117	CcSEcCtD
Caffeine—Irritability—Capecitabine—breast cancer	8.95e-05	0.00117	CcSEcCtD
Caffeine—CYP1A2—endocrine gland—breast cancer	8.91e-05	0.00176	CbGeAlD
Caffeine—Hyperglycaemia—Paclitaxel—breast cancer	8.91e-05	0.00116	CcSEcCtD
Caffeine—ABCB1—embryo—breast cancer	8.9e-05	0.00176	CbGeAlD
Caffeine—Dry skin—Docetaxel—breast cancer	8.88e-05	0.00116	CcSEcCtD
Caffeine—Hypertension—Vinorelbine—breast cancer	8.83e-05	0.00115	CcSEcCtD
Caffeine—Infestation NOS—Paclitaxel—breast cancer	8.8e-05	0.00115	CcSEcCtD
Caffeine—Infestation—Paclitaxel—breast cancer	8.8e-05	0.00115	CcSEcCtD
Caffeine—CYP1A1—endocrine gland—breast cancer	8.79e-05	0.00174	CbGeAlD
Caffeine—Blood creatinine increased—Capecitabine—breast cancer	8.78e-05	0.00115	CcSEcCtD
Caffeine—Cardiac disorder—Gemcitabine—breast cancer	8.76e-05	0.00115	CcSEcCtD
Caffeine—Immune system disorder—Irinotecan—breast cancer	8.75e-05	0.00114	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—breast cancer	8.75e-05	0.00114	CcSEcCtD
Caffeine—Dyspnoea—Tamoxifen—breast cancer	8.7e-05	0.00114	CcSEcCtD
Caffeine—Urine output increased—Methotrexate—breast cancer	8.69e-05	0.00114	CcSEcCtD
Caffeine—Renal failure—Paclitaxel—breast cancer	8.65e-05	0.00113	CcSEcCtD
Caffeine—CYP1B1—lymph node—breast cancer	8.59e-05	0.0017	CbGeAlD
Caffeine—CYP3A5—endocrine gland—breast cancer	8.59e-05	0.0017	CbGeAlD
Caffeine—Dry skin—Capecitabine—breast cancer	8.59e-05	0.00112	CcSEcCtD
Caffeine—Pulmonary oedema—Methotrexate—breast cancer	8.56e-05	0.00112	CcSEcCtD
Caffeine—Rash—Idarubicin—breast cancer	8.53e-05	0.00112	CcSEcCtD
Caffeine—Rash—Raloxifene—breast cancer	8.53e-05	0.00112	CcSEcCtD
Caffeine—Immune system disorder—Gemcitabine—breast cancer	8.53e-05	0.00112	CcSEcCtD
Caffeine—Dermatitis—Raloxifene—breast cancer	8.53e-05	0.00111	CcSEcCtD
Caffeine—Dermatitis—Idarubicin—breast cancer	8.53e-05	0.00111	CcSEcCtD
Caffeine—Dyspnoea—Melphalan—breast cancer	8.52e-05	0.00111	CcSEcCtD
Caffeine—Theophylline—CYP2D6—breast cancer	8.49e-05	0.0457	CrCbGaD
Caffeine—Convulsion—Thiotepa—breast cancer	8.46e-05	0.00111	CcSEcCtD
Caffeine—CYP2C9—endocrine gland—breast cancer	8.46e-05	0.00167	CbGeAlD
Caffeine—Hypertension—Thiotepa—breast cancer	8.43e-05	0.0011	CcSEcCtD
Caffeine—Gastrointestinal disorder—Tamoxifen—breast cancer	8.42e-05	0.0011	CcSEcCtD
Caffeine—Sepsis—Methotrexate—breast cancer	8.34e-05	0.00109	CcSEcCtD
Caffeine—Dyspnoea—Goserelin—breast cancer	8.31e-05	0.00109	CcSEcCtD
Caffeine—Gastritis—Capecitabine—breast cancer	8.3e-05	0.00109	CcSEcCtD
Caffeine—Infection—Vinorelbine—breast cancer	8.29e-05	0.00108	CcSEcCtD
Caffeine—Gastrointestinal disorder—Melphalan—breast cancer	8.25e-05	0.00108	CcSEcCtD
Caffeine—Nervous system disorder—Vinorelbine—breast cancer	8.19e-05	0.00107	CcSEcCtD
Caffeine—Tachycardia—Vinorelbine—breast cancer	8.15e-05	0.00107	CcSEcCtD
Caffeine—Skin disorder—Vinorelbine—breast cancer	8.11e-05	0.00106	CcSEcCtD
Caffeine—Hypersensitivity—Chlorambucil—breast cancer	8.08e-05	0.00106	CcSEcCtD
Caffeine—CYP2E1—endocrine gland—breast cancer	8.02e-05	0.00159	CbGeAlD
Caffeine—Pulmonary oedema—Epirubicin—breast cancer	8.01e-05	0.00105	CcSEcCtD
Caffeine—Haemoglobin—Paclitaxel—breast cancer	7.94e-05	0.00104	CcSEcCtD
Caffeine—Infection—Thiotepa—breast cancer	7.92e-05	0.00104	CcSEcCtD
Caffeine—Haemorrhage—Paclitaxel—breast cancer	7.9e-05	0.00103	CcSEcCtD
Caffeine—Nervous system disorder—Thiotepa—breast cancer	7.82e-05	0.00102	CcSEcCtD
Caffeine—Sepsis—Epirubicin—breast cancer	7.81e-05	0.00102	CcSEcCtD
Caffeine—Tachycardia—Thiotepa—breast cancer	7.78e-05	0.00102	CcSEcCtD
Caffeine—Skin disorder—Thiotepa—breast cancer	7.74e-05	0.00101	CcSEcCtD
Caffeine—CYP3A4—female reproductive system—breast cancer	7.62e-05	0.00151	CbGeAlD
Caffeine—CYP2D6—female reproductive system—breast cancer	7.5e-05	0.00148	CbGeAlD
Caffeine—Infestation—Docetaxel—breast cancer	7.46e-05	0.000976	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—breast cancer	7.46e-05	0.000976	CcSEcCtD
Caffeine—Dyspnoea—Vinorelbine—breast cancer	7.44e-05	0.000973	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—breast cancer	7.41e-05	0.000969	CcSEcCtD
Caffeine—Hypersensitivity—Vinblastine—breast cancer	7.4e-05	0.000968	CcSEcCtD
Caffeine—Renal failure—Docetaxel—breast cancer	7.33e-05	0.000959	CcSEcCtD
Caffeine—Cardiac disorder—Paclitaxel—breast cancer	7.33e-05	0.000959	CcSEcCtD
Caffeine—Hyperglycaemia—Capecitabine—breast cancer	7.31e-05	0.000956	CcSEcCtD
Caffeine—Convulsion—Mitoxantrone—breast cancer	7.31e-05	0.000956	CcSEcCtD
Caffeine—Theophylline—CYP3A4—breast cancer	7.29e-05	0.0392	CrCbGaD
Caffeine—Hypertension—Irinotecan—breast cancer	7.28e-05	0.000952	CcSEcCtD
Caffeine—Hypertension—Mitoxantrone—breast cancer	7.28e-05	0.000952	CcSEcCtD
Caffeine—ABCB1—epithelium—breast cancer	7.26e-05	0.00144	CbGeAlD
Caffeine—Infestation—Capecitabine—breast cancer	7.22e-05	0.000945	CcSEcCtD
Caffeine—Infestation NOS—Capecitabine—breast cancer	7.22e-05	0.000945	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—breast cancer	7.22e-05	0.000945	CcSEcCtD
Caffeine—Gastrointestinal disorder—Vinorelbine—breast cancer	7.21e-05	0.000942	CcSEcCtD
Caffeine—Hypersensitivity—Tamoxifen—breast cancer	7.19e-05	0.00094	CcSEcCtD
Caffeine—Immune system disorder—Paclitaxel—breast cancer	7.14e-05	0.000934	CcSEcCtD
Caffeine—Renal failure—Capecitabine—breast cancer	7.1e-05	0.000929	CcSEcCtD
Caffeine—Hypertension—Gemcitabine—breast cancer	7.09e-05	0.000928	CcSEcCtD
Caffeine—Hypersensitivity—Melphalan—breast cancer	7.04e-05	0.000921	CcSEcCtD
Caffeine—Convulsion—Fluorouracil—breast cancer	7e-05	0.000915	CcSEcCtD
Caffeine—Gastrointestinal disorder—Thiotepa—breast cancer	6.88e-05	0.0009	CcSEcCtD
Caffeine—Malnutrition—Paclitaxel—breast cancer	6.88e-05	0.0009	CcSEcCtD
Caffeine—Hypersensitivity—Goserelin—breast cancer	6.87e-05	0.000898	CcSEcCtD
Caffeine—Infection—Mitoxantrone—breast cancer	6.84e-05	0.000894	CcSEcCtD
Caffeine—Infection—Irinotecan—breast cancer	6.84e-05	0.000894	CcSEcCtD
Caffeine—CYP2D6—female gonad—breast cancer	6.82e-05	0.00135	CbGeAlD
Caffeine—Nervous system disorder—Irinotecan—breast cancer	6.75e-05	0.000883	CcSEcCtD
Caffeine—Haemoglobin—Docetaxel—breast cancer	6.73e-05	0.00088	CcSEcCtD
Caffeine—Tachycardia—Mitoxantrone—breast cancer	6.72e-05	0.000879	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—breast cancer	6.7e-05	0.000876	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—breast cancer	6.69e-05	0.000875	CcSEcCtD
Caffeine—Skin disorder—Mitoxantrone—breast cancer	6.69e-05	0.000875	CcSEcCtD
Caffeine—Nervousness—Paclitaxel—breast cancer	6.68e-05	0.000874	CcSEcCtD
Caffeine—Infection—Gemcitabine—breast cancer	6.66e-05	0.000871	CcSEcCtD
Caffeine—Irritability—Methotrexate—breast cancer	6.66e-05	0.000871	CcSEcCtD
Caffeine—Nervous system disorder—Gemcitabine—breast cancer	6.58e-05	0.00086	CcSEcCtD
Caffeine—Infection—Fluorouracil—breast cancer	6.55e-05	0.000857	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—breast cancer	6.53e-05	0.000854	CcSEcCtD
Caffeine—Haemoglobin—Capecitabine—breast cancer	6.52e-05	0.000852	CcSEcCtD
Caffeine—Skin disorder—Gemcitabine—breast cancer	6.51e-05	0.000852	CcSEcCtD
Caffeine—ABCB1—endometrium—breast cancer	6.51e-05	0.00129	CbGeAlD
Caffeine—Haemorrhage—Capecitabine—breast cancer	6.49e-05	0.000848	CcSEcCtD
Caffeine—Nervous system disorder—Fluorouracil—breast cancer	6.47e-05	0.000846	CcSEcCtD
Caffeine—CYP3A4—endocrine gland—breast cancer	6.45e-05	0.00128	CbGeAlD
Caffeine—Tachycardia—Fluorouracil—breast cancer	6.44e-05	0.000842	CcSEcCtD
Caffeine—CYP2D6—endocrine gland—breast cancer	6.35e-05	0.00126	CbGeAlD
Caffeine—Agitation—Paclitaxel—breast cancer	6.32e-05	0.000827	CcSEcCtD
Caffeine—Cardiac disorder—Docetaxel—breast cancer	6.22e-05	0.000813	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—breast cancer	6.19e-05	0.00081	CcSEcCtD
Caffeine—Rash—Tamoxifen—breast cancer	6.15e-05	0.000805	CcSEcCtD
Caffeine—Hypersensitivity—Vinorelbine—breast cancer	6.15e-05	0.000804	CcSEcCtD
Caffeine—Dermatitis—Tamoxifen—breast cancer	6.15e-05	0.000804	CcSEcCtD
Caffeine—Dyspnoea—Irinotecan—breast cancer	6.14e-05	0.000803	CcSEcCtD
Caffeine—Dyspnoea—Mitoxantrone—breast cancer	6.14e-05	0.000803	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—breast cancer	6.12e-05	0.0008	CcSEcCtD
Caffeine—CYP1A1—lymph node—breast cancer	6.08e-05	0.0012	CbGeAlD
Caffeine—Immune system disorder—Docetaxel—breast cancer	6.05e-05	0.000791	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	6.04e-05	0.00079	CcSEcCtD
Caffeine—Rash—Melphalan—breast cancer	6.02e-05	0.000788	CcSEcCtD
Caffeine—Cardiac disorder—Capecitabine—breast cancer	6.02e-05	0.000787	CcSEcCtD
Caffeine—Dermatitis—Melphalan—breast cancer	6.02e-05	0.000787	CcSEcCtD
Caffeine—ABCB1—uterus—breast cancer	6e-05	0.00119	CbGeAlD
Caffeine—Dry skin—Epirubicin—breast cancer	5.99e-05	0.000783	CcSEcCtD
Caffeine—Dyspnoea—Gemcitabine—breast cancer	5.98e-05	0.000782	CcSEcCtD
Caffeine—Convulsion—Paclitaxel—breast cancer	5.96e-05	0.00078	CcSEcCtD
Caffeine—Gastrointestinal disorder—Irinotecan—breast cancer	5.94e-05	0.000777	CcSEcCtD
Caffeine—Hypertension—Paclitaxel—breast cancer	5.94e-05	0.000777	CcSEcCtD
Caffeine—ABCB1—pituitary gland—breast cancer	5.89e-05	0.00117	CbGeAlD
Caffeine—Dyspnoea—Fluorouracil—breast cancer	5.88e-05	0.000769	CcSEcCtD
Caffeine—Rash—Goserelin—breast cancer	5.88e-05	0.000769	CcSEcCtD
Caffeine—Hypersensitivity—Thiotepa—breast cancer	5.87e-05	0.000768	CcSEcCtD
Caffeine—Dermatitis—Goserelin—breast cancer	5.87e-05	0.000768	CcSEcCtD
Caffeine—ABCB1—adipose tissue—breast cancer	5.87e-05	0.00116	CbGeAlD
Caffeine—Immune system disorder—Capecitabine—breast cancer	5.86e-05	0.000766	CcSEcCtD
Caffeine—Malnutrition—Docetaxel—breast cancer	5.83e-05	0.000763	CcSEcCtD
Caffeine—Gastrointestinal disorder—Gemcitabine—breast cancer	5.79e-05	0.000757	CcSEcCtD
Caffeine—Gastritis—Epirubicin—breast cancer	5.78e-05	0.000756	CcSEcCtD
Caffeine—Gastrointestinal disorder—Fluorouracil—breast cancer	5.69e-05	0.000744	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—breast cancer	5.66e-05	0.00074	CcSEcCtD
Caffeine—Malnutrition—Capecitabine—breast cancer	5.65e-05	0.000738	CcSEcCtD
Caffeine—Infection—Paclitaxel—breast cancer	5.58e-05	0.000729	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—breast cancer	5.54e-05	0.000724	CcSEcCtD
Caffeine—Nervous system disorder—Paclitaxel—breast cancer	5.51e-05	0.00072	CcSEcCtD
Caffeine—Tachycardia—Paclitaxel—breast cancer	5.48e-05	0.000717	CcSEcCtD
Caffeine—Skin disorder—Paclitaxel—breast cancer	5.45e-05	0.000713	CcSEcCtD
Caffeine—ABCB1—female reproductive system—breast cancer	5.39e-05	0.00107	CbGeAlD
Caffeine—Infestation—Methotrexate—breast cancer	5.38e-05	0.000703	CcSEcCtD
Caffeine—Infestation NOS—Methotrexate—breast cancer	5.38e-05	0.000703	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—breast cancer	5.35e-05	0.000699	CcSEcCtD
Caffeine—Renal failure—Methotrexate—breast cancer	5.29e-05	0.000691	CcSEcCtD
Caffeine—ABCB1—adrenal gland—breast cancer	5.26e-05	0.00104	CbGeAlD
Caffeine—Rash—Vinorelbine—breast cancer	5.26e-05	0.000688	CcSEcCtD
Caffeine—Dermatitis—Vinorelbine—breast cancer	5.26e-05	0.000688	CcSEcCtD
Caffeine—ABCB1—bone marrow—breast cancer	5.09e-05	0.00101	CbGeAlD
Caffeine—Hyperglycaemia—Epirubicin—breast cancer	5.09e-05	0.000666	CcSEcCtD
Caffeine—Hypersensitivity—Irinotecan—breast cancer	5.07e-05	0.000663	CcSEcCtD
Caffeine—Hypersensitivity—Mitoxantrone—breast cancer	5.07e-05	0.000663	CcSEcCtD
Caffeine—Convulsion—Docetaxel—breast cancer	5.05e-05	0.000661	CcSEcCtD
Caffeine—Hypertension—Docetaxel—breast cancer	5.03e-05	0.000658	CcSEcCtD
Caffeine—Infestation—Epirubicin—breast cancer	5.03e-05	0.000658	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—breast cancer	5.03e-05	0.000658	CcSEcCtD
Caffeine—Rash—Thiotepa—breast cancer	5.03e-05	0.000657	CcSEcCtD
Caffeine—Dermatitis—Thiotepa—breast cancer	5.02e-05	0.000657	CcSEcCtD
Caffeine—Dyspnoea—Paclitaxel—breast cancer	5.01e-05	0.000655	CcSEcCtD
Caffeine—Renal failure—Epirubicin—breast cancer	4.95e-05	0.000647	CcSEcCtD
Caffeine—ABCB1—female gonad—breast cancer	4.91e-05	0.000972	CbGeAlD
Caffeine—Hypertension—Capecitabine—breast cancer	4.87e-05	0.000637	CcSEcCtD
Caffeine—Hypersensitivity—Fluorouracil—breast cancer	4.86e-05	0.000635	CcSEcCtD
Caffeine—Haemoglobin—Methotrexate—breast cancer	4.85e-05	0.000635	CcSEcCtD
Caffeine—Gastrointestinal disorder—Paclitaxel—breast cancer	4.85e-05	0.000634	CcSEcCtD
Caffeine—Haemorrhage—Methotrexate—breast cancer	4.83e-05	0.000631	CcSEcCtD
Caffeine—Infection—Docetaxel—breast cancer	4.73e-05	0.000618	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—breast cancer	4.71e-05	0.000616	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—breast cancer	4.67e-05	0.00061	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—breast cancer	4.66e-05	0.000609	CcSEcCtD
Caffeine—Infestation—Doxorubicin—breast cancer	4.66e-05	0.000609	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—breast cancer	4.64e-05	0.000607	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—breast cancer	4.62e-05	0.000605	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—breast cancer	4.58e-05	0.000599	CcSEcCtD
Caffeine—Infection—Capecitabine—breast cancer	4.58e-05	0.000599	CcSEcCtD
Caffeine—ABCB1—endocrine gland—breast cancer	4.57e-05	0.000904	CbGeAlD
Caffeine—Haemoglobin—Epirubicin—breast cancer	4.54e-05	0.000594	CcSEcCtD
Caffeine—Nervous system disorder—Capecitabine—breast cancer	4.52e-05	0.000591	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—breast cancer	4.52e-05	0.000591	CcSEcCtD
Caffeine—Tachycardia—Capecitabine—breast cancer	4.5e-05	0.000588	CcSEcCtD
Caffeine—Cardiac disorder—Methotrexate—breast cancer	4.48e-05	0.000586	CcSEcCtD
Caffeine—Skin disorder—Capecitabine—breast cancer	4.48e-05	0.000585	CcSEcCtD
Caffeine—Immune system disorder—Methotrexate—breast cancer	4.36e-05	0.00057	CcSEcCtD
Caffeine—Rash—Mitoxantrone—breast cancer	4.34e-05	0.000568	CcSEcCtD
Caffeine—Rash—Irinotecan—breast cancer	4.34e-05	0.000568	CcSEcCtD
Caffeine—Dermatitis—Mitoxantrone—breast cancer	4.34e-05	0.000567	CcSEcCtD
Caffeine—Dermatitis—Irinotecan—breast cancer	4.34e-05	0.000567	CcSEcCtD
Caffeine—Dyspnoea—Docetaxel—breast cancer	4.24e-05	0.000555	CcSEcCtD
Caffeine—Rash—Gemcitabine—breast cancer	4.23e-05	0.000553	CcSEcCtD
Caffeine—Dermatitis—Gemcitabine—breast cancer	4.22e-05	0.000552	CcSEcCtD
Caffeine—Malnutrition—Methotrexate—breast cancer	4.2e-05	0.00055	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—breast cancer	4.2e-05	0.00055	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—breast cancer	4.19e-05	0.000548	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—breast cancer	4.18e-05	0.000547	CcSEcCtD
Caffeine—Rash—Fluorouracil—breast cancer	4.16e-05	0.000544	CcSEcCtD
Caffeine—Dermatitis—Fluorouracil—breast cancer	4.15e-05	0.000543	CcSEcCtD
Caffeine—Hypersensitivity—Paclitaxel—breast cancer	4.14e-05	0.000541	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—breast cancer	4.11e-05	0.000537	CcSEcCtD
Caffeine—Dyspnoea—Capecitabine—breast cancer	4.11e-05	0.000537	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—breast cancer	4.08e-05	0.000534	CcSEcCtD
Caffeine—Gastrointestinal disorder—Capecitabine—breast cancer	3.98e-05	0.00052	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—breast cancer	3.93e-05	0.000514	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—breast cancer	3.88e-05	0.000507	CcSEcCtD
Caffeine—Nervousness—Epirubicin—breast cancer	3.82e-05	0.0005	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—breast cancer	3.78e-05	0.000494	CcSEcCtD
Caffeine—Convulsion—Methotrexate—breast cancer	3.64e-05	0.000476	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—breast cancer	3.64e-05	0.000476	CcSEcCtD
Caffeine—Agitation—Epirubicin—breast cancer	3.61e-05	0.000473	CcSEcCtD
Caffeine—Rash—Paclitaxel—breast cancer	3.54e-05	0.000463	CcSEcCtD
Caffeine—Dermatitis—Paclitaxel—breast cancer	3.54e-05	0.000463	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—breast cancer	3.53e-05	0.000462	CcSEcCtD
Caffeine—Hypersensitivity—Docetaxel—breast cancer	3.51e-05	0.000459	CcSEcCtD
Caffeine—Convulsion—Epirubicin—breast cancer	3.41e-05	0.000446	CcSEcCtD
Caffeine—Infection—Methotrexate—breast cancer	3.41e-05	0.000446	CcSEcCtD
Caffeine—Hypertension—Epirubicin—breast cancer	3.4e-05	0.000444	CcSEcCtD
Caffeine—Hypersensitivity—Capecitabine—breast cancer	3.39e-05	0.000444	CcSEcCtD
Caffeine—Nervous system disorder—Methotrexate—breast cancer	3.36e-05	0.00044	CcSEcCtD
Caffeine—Agitation—Doxorubicin—breast cancer	3.34e-05	0.000437	CcSEcCtD
Caffeine—Skin disorder—Methotrexate—breast cancer	3.33e-05	0.000436	CcSEcCtD
Caffeine—Infection—Epirubicin—breast cancer	3.19e-05	0.000417	CcSEcCtD
Caffeine—ABCB1—lymph node—breast cancer	3.16e-05	0.000625	CbGeAlD
Caffeine—Convulsion—Doxorubicin—breast cancer	3.15e-05	0.000412	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—breast cancer	3.15e-05	0.000412	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—breast cancer	3.14e-05	0.000411	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—breast cancer	3.13e-05	0.00041	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—breast cancer	3.12e-05	0.000408	CcSEcCtD
Caffeine—Dyspnoea—Methotrexate—breast cancer	3.06e-05	0.0004	CcSEcCtD
Caffeine—Rash—Docetaxel—breast cancer	3e-05	0.000392	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—breast cancer	3e-05	0.000392	CcSEcCtD
Caffeine—Gastrointestinal disorder—Methotrexate—breast cancer	2.96e-05	0.000387	CcSEcCtD
Caffeine—Infection—Doxorubicin—breast cancer	2.95e-05	0.000386	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—breast cancer	2.91e-05	0.000381	CcSEcCtD
Caffeine—Rash—Capecitabine—breast cancer	2.91e-05	0.00038	CcSEcCtD
Caffeine—Dermatitis—Capecitabine—breast cancer	2.9e-05	0.00038	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—breast cancer	2.9e-05	0.000379	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—breast cancer	2.88e-05	0.000377	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—breast cancer	2.86e-05	0.000374	CcSEcCtD
Caffeine—Gastrointestinal disorder—Epirubicin—breast cancer	2.77e-05	0.000362	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—breast cancer	2.65e-05	0.000346	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.56e-05	0.000335	CcSEcCtD
Caffeine—Hypersensitivity—Methotrexate—breast cancer	2.53e-05	0.00033	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—breast cancer	2.36e-05	0.000309	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—breast cancer	2.19e-05	0.000286	CcSEcCtD
Caffeine—Rash—Methotrexate—breast cancer	2.16e-05	0.000283	CcSEcCtD
Caffeine—Dermatitis—Methotrexate—breast cancer	2.16e-05	0.000283	CcSEcCtD
Caffeine—Rash—Epirubicin—breast cancer	2.02e-05	0.000265	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—breast cancer	2.02e-05	0.000264	CcSEcCtD
Caffeine—Rash—Doxorubicin—breast cancer	1.87e-05	0.000245	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—breast cancer	1.87e-05	0.000245	CcSEcCtD
Caffeine—CYP2D6—Metabolism—NCOA1—breast cancer	4.73e-07	3.81e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NCOA1—breast cancer	4.69e-07	3.78e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—STK11—breast cancer	4.66e-07	3.76e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP19A1—breast cancer	4.66e-07	3.76e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTHFR—breast cancer	4.65e-07	3.75e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—breast cancer	4.62e-07	3.73e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—GPX1—breast cancer	4.62e-07	3.73e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP19A1—breast cancer	4.62e-07	3.73e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—STK11—breast cancer	4.62e-07	3.73e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—breast cancer	4.61e-07	3.72e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—FASN—breast cancer	4.61e-07	3.72e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MED12—breast cancer	4.6e-07	3.71e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—DPYD—breast cancer	4.6e-07	3.71e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—COMT—breast cancer	4.6e-07	3.71e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—BCHE—breast cancer	4.59e-07	3.7e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—breast cancer	4.57e-07	3.69e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1A1—breast cancer	4.57e-07	3.69e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAV1—breast cancer	4.55e-07	3.67e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—breast cancer	4.54e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAV1—breast cancer	4.54e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—breast cancer	4.54e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—breast cancer	4.53e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALDOA—breast cancer	4.53e-07	3.65e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—HMOX1—breast cancer	4.51e-07	3.64e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ITPR1—breast cancer	4.5e-07	3.63e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—breast cancer	4.49e-07	3.62e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—breast cancer	4.49e-07	3.62e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—breast cancer	4.45e-07	3.59e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—breast cancer	4.4e-07	3.55e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA3—breast cancer	4.39e-07	3.54e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—breast cancer	4.39e-07	3.54e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—breast cancer	4.38e-07	3.54e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NQO1—breast cancer	4.38e-07	3.53e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC2A1—breast cancer	4.38e-07	3.53e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—breast cancer	4.36e-07	3.52e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A2—breast cancer	4.36e-07	3.52e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—breast cancer	4.34e-07	3.5e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—breast cancer	4.34e-07	3.5e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.34e-07	3.5e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—COMT—breast cancer	4.33e-07	3.49e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—breast cancer	4.31e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—COMT—breast cancer	4.29e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAV1—breast cancer	4.29e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.29e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTR—breast cancer	4.27e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CPT1A—breast cancer	4.27e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCG2—breast cancer	4.27e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—breast cancer	4.27e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP3A4—breast cancer	4.27e-07	3.44e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTHFR—breast cancer	4.26e-07	3.44e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—breast cancer	4.25e-07	3.43e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—HMOX1—breast cancer	4.25e-07	3.43e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.25e-07	3.43e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MAPK3—breast cancer	4.25e-07	3.43e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ITPR1—breast cancer	4.24e-07	3.42e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—HMOX1—breast cancer	4.21e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ITPR1—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NCOR1—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—HRAS—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1B1—breast cancer	4.2e-07	3.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGDS—breast cancer	4.19e-07	3.38e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HBA1—breast cancer	4.17e-07	3.36e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—HRAS—breast cancer	4.15e-07	3.35e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—breast cancer	4.15e-07	3.35e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—breast cancer	4.14e-07	3.34e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—breast cancer	4.14e-07	3.34e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—breast cancer	4.13e-07	3.33e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—breast cancer	4.12e-07	3.32e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.12e-07	3.32e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—breast cancer	4.11e-07	3.32e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.1e-07	3.31e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ABCB1—breast cancer	4.08e-07	3.29e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ACHE—breast cancer	4.07e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—breast cancer	4.07e-07	3.28e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ABCB1—breast cancer	4.04e-07	3.26e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—breast cancer	4.04e-07	3.26e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GPX1—breast cancer	4.03e-07	3.25e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—breast cancer	4.02e-07	3.24e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—breast cancer	4.01e-07	3.23e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NCOA1—breast cancer	4e-07	3.23e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1A1—breast cancer	3.98e-07	3.21e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—breast cancer	3.97e-07	3.21e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—breast cancer	3.97e-07	3.2e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—breast cancer	3.96e-07	3.2e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.96e-07	3.2e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NCOR1—breast cancer	3.96e-07	3.2e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—breast cancer	3.95e-07	3.19e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP19A1—breast cancer	3.95e-07	3.18e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—STK11—breast cancer	3.95e-07	3.18e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAV1—breast cancer	3.93e-07	3.17e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—HRAS—breast cancer	3.93e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PLA2G4A—breast cancer	3.93e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—breast cancer	3.93e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NCOR1—breast cancer	3.93e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—breast cancer	3.91e-07	3.15e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP17A1—breast cancer	3.85e-07	3.1e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—breast cancer	3.82e-07	3.08e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ENO1—breast cancer	3.81e-07	3.07e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS1—breast cancer	3.81e-07	3.07e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GPX1—breast cancer	3.79e-07	3.06e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—breast cancer	3.79e-07	3.06e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—breast cancer	3.76e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GPX1—breast cancer	3.76e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.76e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1A1—breast cancer	3.76e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2D6—breast cancer	3.74e-07	3.01e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—breast cancer	3.72e-07	3e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1A1—breast cancer	3.72e-07	3e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTHFR—breast cancer	3.71e-07	3e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—breast cancer	3.71e-07	2.99e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.7e-07	2.99e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—breast cancer	3.69e-07	2.98e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—COMT—breast cancer	3.67e-07	2.96e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA2—breast cancer	3.67e-07	2.96e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—breast cancer	3.67e-07	2.96e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—breast cancer	3.65e-07	2.95e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—breast cancer	3.64e-07	2.94e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—breast cancer	3.64e-07	2.93e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—HMOX1—breast cancer	3.6e-07	2.91e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—ALB—breast cancer	3.6e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ITPR1—breast cancer	3.59e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—ALB—breast cancer	3.59e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—breast cancer	3.58e-07	2.89e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—FASN—breast cancer	3.56e-07	2.87e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—BCHE—breast cancer	3.54e-07	2.86e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—breast cancer	3.51e-07	2.83e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTHFR—breast cancer	3.5e-07	2.82e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—breast cancer	3.5e-07	2.82e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTHFR—breast cancer	3.47e-07	2.8e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—breast cancer	3.47e-07	2.8e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ABCB1—breast cancer	3.46e-07	2.79e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NOS3—breast cancer	3.44e-07	2.78e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—breast cancer	3.44e-07	2.77e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NOS3—breast cancer	3.43e-07	2.77e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAV1—breast cancer	3.43e-07	2.76e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—breast cancer	3.39e-07	2.74e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—breast cancer	3.39e-07	2.74e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—ALB—breast cancer	3.39e-07	2.74e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NQO1—breast cancer	3.38e-07	2.73e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC2A1—breast cancer	3.38e-07	2.73e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—breast cancer	3.36e-07	2.71e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NCOR1—breast cancer	3.36e-07	2.71e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.36e-07	2.71e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—HRAS—breast cancer	3.24e-07	2.62e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NOS3—breast cancer	3.24e-07	2.62e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1B1—breast cancer	3.24e-07	2.61e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAV1—breast cancer	3.23e-07	2.6e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GPX1—breast cancer	3.21e-07	2.59e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAV1—breast cancer	3.2e-07	2.58e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1A1—breast cancer	3.18e-07	2.57e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HSP90AA1—breast cancer	3.18e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—breast cancer	3.18e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—breast cancer	3.17e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—breast cancer	3.15e-07	2.55e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—breast cancer	3.15e-07	2.54e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—breast cancer	3.15e-07	2.54e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—breast cancer	3.14e-07	2.53e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—breast cancer	3.12e-07	2.52e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ALB—breast cancer	3.11e-07	2.51e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—breast cancer	3.11e-07	2.5e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA1—breast cancer	3.09e-07	2.49e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.06e-07	2.47e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—STK11—breast cancer	3.05e-07	2.46e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP19A1—breast cancer	3.05e-07	2.46e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—breast cancer	2.99e-07	2.42e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NOS3—breast cancer	2.97e-07	2.4e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—breast cancer	2.97e-07	2.39e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTHFR—breast cancer	2.97e-07	2.39e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—breast cancer	2.96e-07	2.39e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—breast cancer	2.94e-07	2.37e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—breast cancer	2.92e-07	2.35e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—breast cancer	2.86e-07	2.31e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—COMT—breast cancer	2.83e-07	2.28e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—breast cancer	2.82e-07	2.27e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HMOX1—breast cancer	2.78e-07	2.24e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ITPR1—breast cancer	2.77e-07	2.24e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—breast cancer	2.75e-07	2.21e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—breast cancer	2.74e-07	2.21e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—breast cancer	2.74e-07	2.21e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—breast cancer	2.74e-07	2.21e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAV1—breast cancer	2.74e-07	2.21e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—breast cancer	2.72e-07	2.19e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ALB—breast cancer	2.71e-07	2.19e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—breast cancer	2.67e-07	2.16e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ABCB1—breast cancer	2.67e-07	2.15e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—breast cancer	2.62e-07	2.11e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.61e-07	2.11e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NOS3—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOR1—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—breast cancer	2.59e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—breast cancer	2.56e-07	2.07e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ALB—breast cancer	2.55e-07	2.06e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ALB—breast cancer	2.53e-07	2.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—breast cancer	2.49e-07	2.01e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GPX1—breast cancer	2.48e-07	2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1A1—breast cancer	2.46e-07	1.98e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NOS3—breast cancer	2.44e-07	1.97e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—breast cancer	2.43e-07	1.96e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—breast cancer	2.42e-07	1.95e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NOS3—breast cancer	2.42e-07	1.95e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—breast cancer	2.39e-07	1.93e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—breast cancer	2.37e-07	1.91e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—breast cancer	2.37e-07	1.91e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTHFR—breast cancer	2.29e-07	1.85e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—breast cancer	2.25e-07	1.82e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—breast cancer	2.23e-07	1.8e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—breast cancer	2.23e-07	1.8e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—breast cancer	2.21e-07	1.79e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—breast cancer	2.19e-07	1.77e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—breast cancer	2.18e-07	1.76e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ALB—breast cancer	2.16e-07	1.74e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAV1—breast cancer	2.11e-07	1.7e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NOS3—breast cancer	2.07e-07	1.67e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—breast cancer	2.07e-07	1.67e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—breast cancer	1.95e-07	1.57e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.94e-07	1.56e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—breast cancer	1.93e-07	1.56e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—breast cancer	1.93e-07	1.56e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.92e-07	1.55e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.91e-07	1.54e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—breast cancer	1.89e-07	1.53e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—breast cancer	1.83e-07	1.47e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—breast cancer	1.69e-07	1.36e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—breast cancer	1.67e-07	1.35e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ALB—breast cancer	1.67e-07	1.35e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—breast cancer	1.65e-07	1.33e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NOS3—breast cancer	1.6e-07	1.29e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—breast cancer	1.58e-07	1.28e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—breast cancer	1.58e-07	1.27e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—breast cancer	1.49e-07	1.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—breast cancer	1.47e-07	1.19e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—breast cancer	1.46e-07	1.18e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—breast cancer	1.46e-07	1.18e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.37e-07	1.11e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—breast cancer	1.37e-07	1.1e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—breast cancer	1.36e-07	1.1e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—breast cancer	1.27e-07	1.03e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—breast cancer	1.19e-07	9.61e-07	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—breast cancer	1.16e-07	9.39e-07	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—breast cancer	1.12e-07	9.05e-07	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—breast cancer	1.11e-07	8.98e-07	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—breast cancer	9.51e-08	7.67e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—breast cancer	8.98e-08	7.25e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—breast cancer	7.34e-08	5.92e-07	CbGpPWpGaD
